BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight® Volumes

  Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced financial results for its fourth quarter ended December 31, 2022 and provided its outlook on business performance for 2023.

  February 28, 2023

   · 

  29 min read
• Business

  OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the fourth quarter and full year ended December 31, 2022.

  February 28, 2023

   · 

  20 min read
• Business

  MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results

  MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced operating and financial results for the fourth quarter and full year 2022.

  February 28, 2023

   · 

  20 min read
• Biotech Bay

  Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference

  Spruce Biosciences, Inc. (Nasdaq: SPRB) today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023 at 2:40 PM ET.

  February 28, 2023

   · 

  1 min read
• Business

  Cutera Announces Fourth Quarter and Full-Year 2022 Financial Results along with 2023 Outlook

  Cutera, Inc., a leading provider of aesthetic and dermatology solutions, reported financial results for the fourth quarter and full-year ended December 31, 2022.

  February 28, 2023

   · 

  13 min read
• Business

  REGENXBIO Reports Fourth Quarter 2022 and Full-Year 2022 Financial Results and Recent Operational Highlights

  REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the fourth quarter and full-year ended December 31, 2022, and recent operational highlights.

  February 28, 2023

   · 

  21 min read
• Biotech Beach

  Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel

  Fulgent Genetics, Inc., a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, announced the immediate availability of their new Beacon787 expanded carrier screening panel.

  February 28, 2023

   · 

  7 min read
• Business

  Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results

  Schrödinger, Inc., whose physics-based computational platform is transforming the way therapeutics and materials are discovered, announced financial results for the fourth quarter and full-year ended December 31, 2022, and provided its financial outlook for 2023.

  February 28, 2023

   · 

  23 min read
• Business

  Natera Reports Fourth Quarter and Full Year 2022 Financial Results

  Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the fourth quarter and year ended December 31, 2022 and provided an update on recent business progress and financial outlook.

  February 28, 2023

   · 

  15 min read
• Business

  NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022.

  February 28, 2023

   · 

  17 min read